skip to Main Content

Dr. Sahai on the Role of Genomic Profiling in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Vaibhav Sahai, MBBS, assistant professor of medicine at the University of Michigan, discusses the role of genomic profiling in pancreatic cancer.

Genomic profiling can be useful in pancreatic cancer, but it more valuable for research than it is for daily practice, explains Sahai. Data suggest that 27% of patients with metastatic pancreatic cancer may actually have a targetable mutation; however, only 3% of these patients are paired with a therapeutic option. Watch here . . . 


Back To Top